SBFM Earnings

Quarterly EPS
$-9.40
Q3 2024
$-25.44
Q4 2024
$-4.40
Q1 2025
$-3.94
Q2 2025
$-1.90
Q3 2025
$-2.40
Q4 2025
$-2.50
Q1 2026
$-1.15
Q2 2026
Latest Revenue9.3M
Latest Net Income-1564048
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.159.3M-1564048-1.6%+70.8%
Q1 2026-$2.508.1M-1243869-9.1%+43.2%
Q4 2025-$2.408.6M-2140927-10.6%+90.6%
Q3 2025-$1.909.4M-883820+11.6%+79.8%
Q2 2025-$3.949.4M-1770834+1.2%+96.0%
Q1 2025-$4.408.9M-1179771+18.0%+78.0%
Q4 2024-$25.449.6M-2158212+24.9%+90.1%
Q3 2024-$9.408.4M-1197803+41.6%+98.1%
Q2 2024-$99.409.3M-494300
Q1 2024-$20.007.5M-1283801
Q4 2023-$257.527.7M-1250024
Q3 2023-$507.206.0M-651482
Sunshine Biopharma (SBFM) — Earnings